Survival RateCell SurvivalSurvival AnalysisDisease-Free SurvivalSurvivalGraft SurvivalTreatment OutcomeKaplan-Meier EstimatePrognosisTime FactorsRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsNeoplasm StagingLung NeoplasmsProportional Hazards ModelsCombined Modality TherapyFollow-Up StudiesAntineoplastic AgentsCisplatinBrain NeoplasmsAdenocarcinomaNeoplasm Recurrence, LocalLiver NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungTumor Markers, BiologicalMultivariate AnalysisFluorouracilImmunohistochemistryDisease ProgressionApoptosisDrug Administration ScheduleBreast NeoplasmsCell Line, TumorDeoxycytidineMice, Inbred C57BLGlioblastomaCarcinoma, HepatocellularStomach NeoplasmsDoxorubicinColorectal NeoplasmsProspective StudiesCyclophosphamidePancreatic NeoplasmsMice, Inbred BALB CRisk FactorsLymphatic MetastasisAntimetabolites, AntineoplasticCarcinoma, Squamous CellDisease Models, AnimalChemotherapy, AdjuvantCohort StudiesGliomaGraft RejectionTransplantation, HomologousCarcinomaPaclitaxelAge FactorsOvarian NeoplasmsNeoplasm TransplantationPalliative CareSignal TransductionVincristineCell ProliferationPredictive Value of TestsGene Expression Regulation, NeoplasticNimustineDose-Response Relationship, DrugEtoposideBile Duct NeoplasmsRemission InductionCarcinoma, Small CellSkin TransplantationNeoplasmsNeoplasm InvasivenessMelanomaLeucovorinCamptothecinCarboplatinCholangiocarcinomaRecurrenceEsophageal NeoplasmsAntibodies, MonoclonalSupratentorial NeoplasmsRisk AssessmentInfusions, IntravenousDacarbazineOrganoplatinum CompoundsRadiotherapy, AdjuvantRadiotherapy DosageAntineoplastic Agents, PhytogenicMutationHeart TransplantationChemoembolization, TherapeuticBone NeoplasmsRegistriesTaxoidsActuarial AnalysisLife TablesKidney Neoplasms